(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

(2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

Intermediate for Empagliflozin. Empagliflozin (trade name: Jardiance) is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2). Empagliflozin is used for the treatment of type 2 diabetes in adults. Empagliflozin has been approved by the U.S Food and Drug Administration on August 1, 2014.

Specifications

Product Name:                  (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol

Synonyms:                         N/A

CAS Number:                     1279691-36-9

Molecular Weight:            480.9413

Molecular Formula:          C24H29ClO8

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               ClC3=C(C=[C@@]([C@]4(OC)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C=C3)CC(C=C2)=CC=C2O[C@@H]1COCC1

  • $138.00
  • Ex Tax: $138.00

Available Options